From therapeutic proteins and monoclonal antibodies, Enzene animal health combines cutting-edge technology with deep biologics expertise to accelerate your animal health program.
A Continuously Innovative Development and Manufacturing Organization (CIDMO) with a custom designed facility for USDA-compliant development and manufacturing of veterinary biologics.
Enzene animal health was the first CDMO to offer its partners a facility designed to comply U.S. Department of Agriculture (USDA) guidance and regulation for the development and manufacturing of veterinary biologics in the U.S., delivering trusted expertise, innovative technology, and cost-effective solutions for animal health programs.
As a pioneering CIDMO, Enzene offers its animal health partners a powerful combination of:
Scalable, flexible, and shown to significantly reduce waste and cost of goods sold (COGS).
First custom designed facility for USDA-compliant development and manufacturing of veterinary biologics in the U.S.
Track record of producing multiple GLP/GMP-compliant batches used in efficacy studies and for animal health programs.
With fewer hand-offs and the continuous monitoring of our truly continuous biomanufacturing technology, we help de-risk your development and commercialization journey.
Enzene is committed to continuously innovative technologies that meet your highest expectations.
Our proprietary EnzeneX™ 2.0 platform incorporates Enzene’s fully-connected continuous manufacturing™ (FCCM™) technology, which provides flexible biomanufacturing with both scale-on, scale-out, and scale-up capabilities. this means that from tech transfer on, your project can seamlessly transition from early development to commercial scale—without delays or compromises.
High productivity. Lower COGS. Built for animal health.
Animal health programs require efficiency and affordability. through our best-in-class facilities featuring the EnzeneX™ platform, and our experienced and well-trained employees, we deliver: